Get the Stockscreener App
14.20
6.05%
0.81
After Hours:
14.19
-0.010
-0.07%
Mind Medicine Inc stock is traded at $14.20, with a volume of 5.32M.
It is up +6.05% in the last 24 hours and up +20.44% over the past month.
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
See More
Previous Close:
$13.39
Open:
$13.455
24h Volume:
5.32M
Relative Volume:
3.26
Market Cap:
$1.08B
Revenue:
$11.40B
Net Income/Loss:
$-95.73M
P/E Ratio:
-5.7959
EPS:
-2.45
Net Cash Flow:
$-64.37M
1W Performance:
+14.70%
1M Performance:
+20.44%
6M Performance:
+122.22%
1Y Performance:
+125.40%
1-Day Range:
$13.23
$14.43
1-Week Range:
$12.41
$14.43
52-Week Range:
$4.70
$14.43
Mind Medicine Inc Stock (MNMD) Company Profile
Name
Mind Medicine Inc
Sector
Industry
Phone
212-220-6633
Address
ONE WORLD TRADE CENTER, NEW YORK
Compare MNMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
14.20 | 1.02B | 11.40B | -95.73M | -64.37M | -2.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-25 | Initiated | Needham | Buy |
| Aug-04-25 | Resumed | Oppenheimer | Outperform |
| Jan-28-25 | Initiated | Evercore ISI | Outperform |
| Dec-20-24 | Initiated | Chardan Capital Markets | Buy |
| Oct-14-24 | Resumed | Leerink Partners | Outperform |
| Jul-24-24 | Initiated | ROTH MKM | Buy |
| May-29-24 | Initiated | Robert W. Baird | Outperform |
| Apr-15-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | Canaccord Genuity | Buy |
| Dec-09-22 | Resumed | ROTH Capital | Buy |
| Nov-16-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-26-22 | Initiated | Oppenheimer | Outperform |
| Aug-10-22 | Initiated | Cantor Fitzgerald | Overweight |
| May-04-22 | Initiated | ROTH Capital | Buy |
| Jun-28-21 | Initiated | Maxim Group | Buy |
View All
Mind Medicine Inc Stock (MNMD) Latest News
Predicting Mind Medicine (MindMed) Inc. trend using moving averages2025 Support & Resistance & Reliable Breakout Forecasts - newser.com
How analysts revise price targets for Mind Medicine (MindMed) Inc. (MMQ) stock2025 Analyst Calls & AI Enhanced Trade Execution Alerts - newser.com
Will Mind Medicine (MindMed) Inc. stock benefit from commodity pricesRate Cut & Fast Gain Swing Trade Alerts - newser.com
Will Mind Medicine (MindMed) Inc. price bounce be sustainableJuly 2025 Summary & Verified Technical Signals - newser.com
Will Mind Medicine (MindMed) Inc. rebound enough to break evenQuarterly Market Summary & Weekly Chart Analysis and Guides - newser.com
Is Mind Medicine (MindMed) Inc. stock overvalued by current metricsMarket Trend Summary & Accurate Trade Setup Notifications - newser.com
How Mind Medicine (MindMed) Inc. (MMQ) stock benefits from digital adoptionQuarterly Portfolio Report & Breakout Confirmation Trade Signals - newser.com
Will Mind Medicine (MindMed) Inc. stock outperform value stocksJuly 2025 Movers & Safe Capital Growth Trade Ideas - newser.com
Will Mind Medicine (MindMed) (MNMD)'s Fresh Capital Shape a New Phase of Strategic Ambitions? - simplywall.st
Risk vs reward if holding onto Mind Medicine (MindMed) Inc.2025 Pullback Review & Verified Momentum Watchlists - newser.com
What momentum shifts mean for Mind Medicine (MindMed) Inc.Portfolio Value Report & Safe Swing Trade Setups - newser.com
Mind Medicine (MindMed) (NASDAQ:MNMD) Sets New 12-Month HighShould You Buy? - MarketBeat
Will Mind Medicine (MindMed) Inc. stock outperform Dow Jones indexPortfolio Growth Summary & Long-Term Growth Stock Strategies - newser.com
Can Mind Medicine (MindMed) Inc. stock double in next 5 years2025 Fundamental Recap & AI Driven Stock Price Forecasts - newser.com
Is Mind Medicine (MindMed) Inc. (MMQ) stock resilient in recession scenariosWeekly Market Summary & Real-Time Price Movement Reports - newser.com
Mind Medicine stock hits 52-week high at 14.31 USD - Investing.com
Mind Medicine stock hits 52-week high at 14.31 USD By Investing.com - Investing.com Nigeria
Why Mind Medicine (MNMD) Is Up 8.2% After $225M Equity Raise to Fund R&D and Acquisitions - Yahoo Finance
How forex fluctuations impact Mind Medicine (MindMed) Inc. (MMQ) stockEarnings Recap Summary & Real-Time Volume Analysis Alerts - newser.com
Why Mind Medicine (MindMed) Inc. (MMQ) stock attracts HNW investorsGlobal Markets & Stepwise Trade Execution Plans - newser.com
Mind Medicine (MindMed) (MNMD) Projected to Post Earnings on Thursday - MarketBeat
Is Mind Medicine (MindMed) Inc. (MMQ) stock cheap vs fundamentals2025 Growth vs Value & Low Risk Profit Maximizing Plans - newser.com
Best data tools to analyze Mind Medicine (MindMed) Inc. stockPortfolio Value Report & Weekly Momentum Picks - newser.com
MindMed to Report Q3 2025 Financial Results on November 6, 2025 - Business Wire
symbol__ Stock Quote Price and Forecast - CNN
Mind Medicine Inc. Announces Pricing of $225 Million Public Offering - Investing News Network
Mind Medicine says it announces pricing of $225 million public offering at $12.25 per share - MarketScreener
Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public Offering - Business Wire
Mind Medicine Inc. Announces Proposed Public Offering - Investing News Network
Mind Medicine Inc Stock (MNMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):